2009 H1N1 July 25th update

2009 H1N1 Info gathered by Mona Youssef

Study has shown virus to be different from the normally circulating North American pig virus. It has two genes from flu viruses that normally circulate in pigs in Europe and Asia , avian genes and human genes. "quadruple reassortant" virus How is it then that it made its first appearance in Mexico and the US?

Genomic mapping of the virus revealed that it has been present and circulating in pigs for the past 7.5 to ten years (obviously undetected due to laxity in surveillance of pigs).

Charecteristics
Influenza virus can survive on environmental surfaces and remain infectious for up to 2-8 hours after being deposited on the surface.
Virus is destroyed by :
heat 75-100 degrees Celcius.
chemical germicides : chlorine, hydrogen peroxide, detergents (soap), iodophors (iodine-based antiseptics), and alcohols.
*wipes or gels with alcohol in them should be rubbed into hands
until they are dry.
A person can sneeze on someone’s luggage in an airport, and start an outbreak in a country without even entering it!

Swine flu virus (Not novel H1N1)
Like all influenza viruses, swine flu viruses change constantly.
Pigs can be infected by avian influenza and human influenza viruses as well as swine influenza viruses.
When influenza viruses from different species infect pigs, the viruses can reassort (i.e. swap genes) and new viruses that are a mix of swine, human and/or avian influenza viruses can emerge.
Over the years, different variations of swine flu viruses have emerged. There are currently four main influenza type A virus subtypes that have been isolated in pigs: H1N1, H1N2, H3N2, and H3N1.
Most of the recently isolated influenza viruses from pigs have been H1N1 viruses.
H3 subtypes infect older population and tend to be more severe .

Drinking water?
No completed research for novel H1N1 virus.
Free chlorine levels typically used in drinking water treatment are adequate to inactivate highly pathogenic H5N1 avian influenza.
It is likely that other influenza viruses such as novel H1N1 would also be similarly inactivated by chlorination.

Swimming Pools
No completed research for novel H1N1 virus.
Free chlorine levels recommended by CDC (1–3 parts per million [ppm or mg/L] for pools and 2–5 ppm for spas) are adequate to disinfect avian influenza A (H5N1) virus.
It is likely that other influenza viruses such as novel H1N1 would also be similarly inactivated by chlorination.

Dealing with the Deceased
Transport of deceased persons does not require any additional precautions when bodies have been secured in a transport bag. Hand hygiene should be performed after completing transport.
For deceased persons with confirmed, probable, or suspect novel influenza A (H1N1):
limit contact with the body in health care settings to close family members
Direct contact with the body is discouraged
Necessary contact may occur as long as hands are washed immediately with soap and water.
NO need for mass burials yet….

Autopsy :
Standard Precautions.
Additional respiratory protection is needed procedures that generate aerosols (e.g., use of oscillating saws).
minimize the number of personnel participating in post mortem examinations.
Follow standard safety procedures for preventing percutaneous injuries during autopsy.

He says ice-cream made him feel better, and Thank God has now recovered full health. But the rest of the planet has a quick –paced pandemic marching on…. 'Patient Zero' in Swine Flu Outbreak Identified as 5-Year-Old Mexican Boy: Edgar Hernandez

Timeline

April 23 : S-OIV (swine origin influenza virus) confirmed,
same strain detected in two California children as in Mexico.
PAHO informed of Mexico cluster of S-OIV
MidMarch : La Gloria,Veracruz, 60% of the town's population is sickened by a respiratory illness of unknown provenance. Mexico April 16 : Mexico Authorities notify the PAHO (Pan American Health Organization) of the atypical pneumonia. Canadian labs

WHO
April 24: 2009 H1N1 first disease outbreak notice.
April 25: WHO Director General declares a formal
“ Public health emergency of international concern”
April 27: “containment of the outbreak is not feasible”
pandemic alert raised from phase 3 to phase 4.
April 29: phase 4 to phase 5.
June 11: phase 5 to phase 6.
During this time interim, the WHO was vastly criticized for not announcing phase 6

WHO Report 95 AFFECTED COUNTRIES Nothing’s holding this virus back…….!!!

keyword A pandemic means an epidemic of an infectious disease, that spreads throughout a large number of people and can spread worldwide. A pandemic begins when : there is person-to-person sustained transmission on multiple continents.

The World Health Organization uses a six stage phase for alerting the general public to an outbreak

Phase 1 – animal to animal transmission. Phase 2 – an animal influenza virus is capable of human infection. Phase 3 - small outbreaks among close populations but not through human to human contact. Phase 4 - Human to human transmission Phase 5 - spread across two countries or more in one of the WHO regions (continents). Phase 6 – spread across two countries or more in one of the WHO regions plus spread to another WHO region.

W.H.O. identifies the following six epidemiological sub-regions. - African Region - Eastern Mediterranean Region - European Region - Region of the Americas - South-East Asian Region - Western Pacific Region

Even an island in the middle of the ocean isn’t out of its reach….

June 15/2009

In one week , the United Nations agency raised the alert level twice, from phase 3 to phase 5, in response to the sustained transmission of H1N1 in Mexico and the United States. ( 1976 swine flu Hsw1N1 outbreak never passed phase 3. The vaccine developed caused 10 per million Guillain Barre syndrome as compared to the 1-2 per million with the seasonal flu vaccine and was banned.) Graveness of the situation

19/6/2009 WHO report 19/6/2009 WHO report Country Cumulative total Newly confirmed since the last reporting period Cases Deaths Cases Deaths Country Cumulative total Newly confirmed since the last reporting period Cases Deaths Cases Deaths Country Cumulative total Newly confirmed since the last reporting period Cases Deaths Cases Deaths Argentina 918 4 185 3 Australia 2199 0 87 0 Austria 8 0 1 0 Bahamas 2 0 0 0 Bahrain 12 0 0 0 Barbados 4 0 1 0 Belgium 19 0 0 0 Bermuda, UKOT 1 0 0 0 Bolivia 11 0 0 0 Brazil 96 0 17 0 British Virgin Islands, UKOT 1 0 0 0 Bulgaria 2 0 0 0 Canada 4905 12 856 5 Cayman Islands, UKOT 4 0 0 0 Chile 3125 2 790 0 China 519 0 137 0 Colombia 60 1 7 0 Costa Rica 149 1 0 0 Cuba 15 0 8 0 Cyprus 1 0 0 0 Czech Republic 5 0 1 0 Denmark 22 0 7 0 Dominica 1 0 0 0 Dominican Republic 93 1 0 0 Ecuador 86 0 0 0 Egypt 29 0 3 0 El Salvador 160 0 35 0 Estonia 5 0 1 0 Finland 13 0 1 0 France 131 0 13 0 French Polynesia, FOC 1 0 0 0 Martinique, FOC 1 0 0 0 Germany 238 0 43 0 Greece 31 0 8 0 Guatemala 153 1 25 0 Honduras 108 0 8 0 Hungary 7 0 3 0 Iceland 4 0 0 0 India 30 0 0 0 Ireland 16 0 4 0 Israel 219 0 67 0 Italy 88 0 16 0 Jamaica 14 0 2 0 Japan 690 0 24 0 Jordan 2 0 0 0 Korea, Republic of 84 0 19 0 Kuwait 18 0 0 0 Laos 1 0 1 0 Lebanon 12 0 1 0 Luxembourg 2 0 0 0 Malaysia 23 0 6 0 Mexico 7624 113 1383 5 Morocco 8 0 5 0 Netherlands 87 0 19 0 Netherlands Antilles, Curaçao * 3 0 2 0 Netherlands Antilles, Sint Maarten 1 0 1 0 New Zealand 216 0 89 0 Nicaragua 144 0 26 0 Norway 17 0 4 0 Oman 3 0 3 0 Panama 272 0 0 0 Papua New Guinea 1 0 1 0 Paraguay 27 0 2 0 Peru 141 0 29 0 Philippines 311 0 118 0 Poland 7 0 0 0 Portugal 5 0 2 0 Qatar 3 0 0 0 Romania 18 0 2 0 Russia 3 0 0 0 Samoa 1 0 0 0 Saudi Arabia 22 0 5 0 Singapore 77 0 28 0 Slovakia 3 0 0 0 South Africa 1 0 1 0 Spain 512 0 13 0 Sri Lanka 1 0 0 0 Suriname 11 0 11 0 Sweden 43 0 6 0 Switzerland 27 0 0 0 Thailand 518 0 208 0 Trinidad and Tobago 18 0 13 0 Turkey 20 0 4 0 Ukraine 1 0 0 0 United Arab Emirates 2 0 1 0 United Kingdom 1752 1 291 0 Isle of Man, Crown Dependency 1 0 0 0 Jersey, Crown Dependency 1 0 0 0 United States of America 17855 44 0 0 Uruguay 36 0 0 0 Venezuela 60 0 15 0 Viet Nam 27 0 0 0 West Bank and Gaza Strip 5 0 3 0 Yemen 4 0 3 0 Grand Total 44287 180 4667 13

Countries of origin. Mixing of NH1N1 with seasonal flu virus could result in a strain resistant to tamiflu(NH1N1 is already resistant to other antivirals Mixing with H5N1 could produce strains capable of human to human transmission(Death toll of H5N1 is app. 66%) Australia 2199 0 87 0 Chile 3125 2 790 0 Egypt 29 0 3 0 Mexico 7624 113 1383 5 United States of America 17855 44 0 0 Grand Total 44287 180 4667 13 Country 19/6/2009 Cumulative total Newly confirmed since the last reporting period (17/6) Cases Deaths Cases Deaths

And then Fate has it that the first detected viral strains resistant to tamiflu would show up in China! NOT Australia, and Not Chilli

Consequences of a declaration of a full pandemic
Institution of pandemic response plans, which may include measures affecting
hospitals, schools or public events.
Provision of support for developing countries including: drugs, diagnostic tests,
and medical staff
WHO would be expected to make an announcement to specify whether
manufacturers should switch from making seasonal to pandemic flu vaccines.

June 5 CDC Report:
Testing
CDC has developed a PCR diagnostic test kit
Distributed test kits throughout U.S. nation as well as internationally.
Vaccine
CDC has isolated the new H1N1 virus, made a candidate vaccine virus that can be
used to create vaccine.
( Novartis manufactures first vaccine June 11 2009 )
Strategic National Stockpile
CDC has deployed 25 percent of the supplies in the Strategic National Stockpile
(SNS) to all states in the continental United States and U.S. territories.
This included antiviral drugs, personal protective equipment, and respiratory
protection devices.

Previous Global Pandemics

1918 - Spanish Flu (originated in birds). First hit soldiers in Europe during World War I, as their immune systems were weakened by war. The mortality rate was highest between 20 to 50 year olds. There was never any vaccine developed, after about 18 months, the virus seemed to just disappear . The final death toll was written as 40 million people worldwide . Soldiers whose immunity was weakened by war. Many of the victims who have died in Mexico have been young and otherwise healthy. society's healthiest demographic

1957 - Asian Flu This flu started in birds in Asia. In September schools and public places started closing in an effort to contain the virus. In December the virus started to subside , but reappeared in January. over two million people died Reappeared

1968 - The Hong Kong Flu This is the mildest pandemic It was first found in the early months of 1968 in Hong Kong, and was declared a global pandemic by December. Children were out of school and were therefore not able to spread it as much. It made a mild reappearance in 1970 and 1972 . it claimed about a million lives Seasonal influenza normally claims app. ¼ to ½ a million lives yearly. Reappeared…!!!

What we do know

Disease spectrum ranges from very mild self-limited disease to Death. Novel H1N1 virus tends to affect younger people just like the seasonal H1N1. (Older adults were shown to possess serum neutralizing antibodies to the new virus, most likely due to cross‐immunity with human H1N1 viruses. ) Novel H1N1 spreads just as easily as regular winter flu . Novel H1N1 virus tends to affect younger people just like the seasonal H1N1. (Older adults were shown to possess serum neutralizing antibodies to the new virus, most likely due to cross‐immunity with human H1N1 viruses. )

The southern hemisphere is about to enter winter , when seasonal flu cases normally spike.
We have to be prepared for changes in:
The amount of illness
The severity of illness
The characteristics of the virus
The reactions of our communities
Early evidence in the southern hemisphere points to novel H1N1 potentially crowding out the seasonal flu viruses which is something that's been seen in previous pandemics .

Seasonal flu vaccine production is to continue as is, in an attempt to reduce the chances of the viruses mingling together in the same environment.
Simultaneous circulation of the seasonal flu strains with the Novel H1N1 raises the possibility of mixing of the strains. Seasonal H1N1 virus that we've had this past year is resistant to Tamiflu .

Influenza is unpredictable.

Characteristics of reported cases of influenza A(H1N1) by country Of note , the prevailing clinical picture in other countries has been GIT related.

Data limitations :
countries are using different surveillance methods and case definitions.
Caution must be exercised in interpreting information such as age as it may reflect
patterns of travel or the occurrence of outbreaks in special settings such as schools.
Due to early stage of disease spread and the limited number of settings :
Incomplete picture of the epidemiological and clinical characteristics of the
virus.
Estimates of important epidemiological parameters such as incubation
period, attack rate and case fatality ratio may not be broadly applicable.

WHO currently recommends shifting surveillance efforts to following trends in illness cases rather than testing all ill patients which can severely stress national resources. Top priority is to determine which groups of people are at highest risk of serious disease. WHO is now relying on information obtained from special research and clinical studies and other data provided by countries directly through frequent expert teleconferences on clinical, virological and epidemiological aspects of the pandemic. WHO Pandemic (H1N1) 2009 briefing note 4 July 24/2009

VACCINE

A review of 2009 production status for northern hemisphere seasonal vaccine indicates that:
Industry plans to produce approximately 480 million doses of trivalent seasonal
vaccine in 2009.
Of this, 35 0 and 430 million doses will be available by 30 June and 31 July 2009,
respectively.
For influenza A (H1N1), it is estimated that up to 4.9 billion doses could be produced
over a 12‐month period IF there is initiation of a full‐scale production.
In this situation, there is a potential access for the UN of supplies of up to 400 million
doses.
A lot of Ifs……..

Currently available data indicate that:
Immunization with recent or shortly to be available trivalent seasonal vaccine is unlikely to provide public health benefits in terms of protection against influenza A (H1N1).
Unknowns:
optimal antigen content,
the required number of doses,
the required intervals between doses
and the interchangeability of different products is currently unknown for influenza A (H1N1) vaccines.
the safety profile

After considering the following issues:
the need for any recommendation to balance both risks and benefits,
the current uncertainty about the severity of influenza A (H1N1) illness,
the readiness of vaccine seed strains and reagents for large‐scale vaccine production,
the current status of production of seasonal vaccine for the Northern hemisphere,
The risks associated with a premature cessation of seasonal vaccine production,

Two doses of vaccine may be needed.
The combination of A (H1N1) vaccine with trivalent seasonal vaccine would have
significant regulatory limitations.
Moving into production now could result in starting vaccine production with strains of
lower growth potential, as was the case for H5N1 A/Vietnam/2004. The yields were less
than 50% of those usually obtained with seasonal vaccine viruses.
(currently NH1N1 yields are 25% to 50 % of the normal yields for seasonal influenza)
Using a poorly growing A (H1N1) virus could reduce global supplies of A (H1N1)
vaccine.
The Working Group Declares that:
It is premature to recommend commercial‐scale production of influenza A (H1N1)
vaccine.

The Working Group did make the following recommendations for immediate action:
The WHO Secretariat, should recommend which vaccine viruses should be used for vaccine development as soon as possible
(ii) Essential reagents to calibrate antigenic content should be made available as a
priority
(iii) The WHO Secretariat is encouraged to collaborate actively with its Collaborating
Centres,Essential Regulatory Laboratories, and with industry, to assess the growth
property of vaccine viruses and identify those with best growth potential , in order to
maximize output of vaccine.

(iv) Manufacturers are urged to develop clinical trial batches and accelerate initiation of clinical trials of influenza A (H1N1) vaccines and to start preparing for a potential future recommendation to move to commercial‐scale production. (v) The above activities should not interfere with the present production of the Northern hemisphere seasonal vaccines (vi) The number of needed doses of A (H1N1) vaccine will depend on the spread of influenza A (H1N1) virus in the next few weeks and on a better definition of the groups to be targeted (vii) An evidence‐based recommendation for the groups to be targeted for vaccination still requires more data

Medpage 7/24/2009 from an article written by Dr. Zalman S. Agus: The FDA is likely to approve 2009 H1N1 (swine flu) vaccines before trial data can prove their safety and effectiveness against the virus. Having a licensed vaccine doesn't mean that an immunization program will kick-off immediately -- that call has to come from the Secretary of Health and Human Services (HHS).

Of the five companies applying for FDA approval -- Novartis, sanofi pasteur, CSL Biotherapies, GlaxoSmithKline, and MedImmune -- only CSL has already started human trials. The Australian company, which provides seasonal flu vaccines to the U.S., inoculated its first human trial participant Wednesday.
Meanwhile, the NIH announced it was set to begin clinical trials in the United States of vaccines made by sanofi-pasteur and CSL.

If the vaccine is ineffective at stimulating an immune response, the FDA might have to issue an "emergency use authorization" for an oil-in-water adjuvant that sparks a stronger reaction in the immune system, but causes more side effects. Two companies, GlaxoSmithKline and Novartis, are applying for approval for vaccines that contain oil-in-water adjuvants. The NIH is also conducting a trial of an adjuvant-enhanced vaccine. Adjuvanted flu vaccines have been used for a decade in Europe and have not been shown to harm vulnerable populations, such as children.(Theodore Eickhoff). The government has already purchased a supply of 120 million adjuvant doses that it will add to its antigen supply if it there is a shortage of the vaccine, or if the standard versions are shown to be ineffective.

Human infection with 2009 H1N1virus: clinical observations from Mexico and other affected countries, May 2009

Presenting Manifestations:
Fever: may be absent in one out of six hospitalized patients.
Dehydration
Shortness of breath
Myalgia
Sever malaise
Tachycardia
Tachypnoea
Low O2 sat.
Hypotension
Cyanosis
Acute myocarditis
Cardiopulmonary arrest
*Diarrhoea,nausea,vomiting: uncommon in hospitalized pts (38% of US outpatients)
*NO ENCEPHALITIS TO DATE

Hospitalization :
2-5% of confirmed cases in US and Canada
6% of confirmed cases in Mexico
(in Mexico 33% of hospitalized patients required ventilation as
compared to only 13% in California)
Fatalities are mainly from rapid progression to: ARDS
Renal failure
Multiorgan failure
The highest rates of hospitalization are actually in children under 5, and the next highest rates are in those people 5 to 24.
Preparing ICUs…

Comorbidities associated with complications:
(71% of the hospitalized patients have occurred in people who have an underlying condition )
Pregnancy:2/5 developed complications: Spontaneous abortion
Premature ruptured
membrane
Asthma and other lung disease
Diabetes
Morbid Obesity
Autoimmune disorders
Associated immunosuppressive therapy
Neurological
Cardiovascular disease

Lab:
Leucocytosis/leucopenia
Lymphopenia
Elevated aminotransferases
Elevated LDH was found (retrogradely) in 100% of 16 dead patients
In some extremely elevated CPK
1/2 hospitalized pts showed some degree of Renal insufficiency
( 2ry to rhabdomyolysis and myoglobinuria)
Co-infections with strept. pneumonia and adenovirus have been reported in some
Mexican cases.

Pathology (postmortem)
ARDS 2ry to 1ry viral pneumonia including :
diffuse alveolar damage
Peribronchial and perivascular lymphoctic infiltrates
hyperplastic airway changes
bronchiolitis obliterans
Muscle biopsy: sk ms necrosis

WHO Guidance

Mild Cases:
Supportive: Paracetamol, flds…
*NO SALICYLATES IN CHILDREN/ YOUNG ADULTS:
REYE'S SYNDROME
Antivirals : *best within first 48 hours
*Early administration in at-risk pts ie those with co-morbidities/pregnancy…
*Neuraminidase inhibitors: oral Oseltamivir
Inhaled Zanamivir
(N H1N1 is resistant to M2 ion channel inhibitors: Amantadine
Rimantadine )
Adequate control precautions: cough etiquette
Hand hygiene
Natural ventilation

Hospitalized pts:
Antivirals
Pneumonia management like avian (antibiotics)
Resp. Support: early detection
Correction of hypoxia with supplemental O2
or mech. Vent as necessary
when mech. vent is indicated: low volume
low pressure
lung protective vent. Strategy for ARDS
Steroids:
Avoid routine use, no benefit was reported .
Higher doses associated with serious SE:
evidence of increased viral replication in SARS and other resp. viral infections.
Increased mortality in Avian.

Unanswered questions:
Effect of:
Smoking
Air pollution
Faeces and vomitus
Role of flies?

Roooooar! …… . Nobody’s scared of me nomore! Round and round she goes, where it stops , nobody knows…

Hey, who said that?

swine flu in humans can vary in severity from mild to severe. Severe disease with pneumonia, respiratory failure and even death

How Flu Spreads, Droplet infection
Respiratory droplets of coughs and sneezes propelled through the air
and deposited on the mouth or nose or eyes of people nearby.
when a person touches respiratory droplets on another person or an
object and then touches their own mouth or nose or eyes (or someone
else’s mouth or nose or eyes) before washing their hands.

People with swine flu who are cared for at home should: I wish everyone could have a home like this

Check with their health care provider about any special care they might need and about antivirals if they are pregnant or have a health condition such as diabetes, heart disease, asthma, or emphysema.
stay home for 7 days after the start of their symptoms or until they have been symptom-free for 24 hours, whichever is longer
get plenty of rest.

drink clear fluids (such as water, broth, sports drinks, electrolyte beverages for infants) to keep from being dehydrated
cover coughs and sneezes. Clean hands with soap and water or an alcohol-based hand rub often and especially after using tissues and after coughing or sneezing into hands.
avoid close contact with others – do not go to work or school while ill
be watchful for emergency warning signs that might indicate the need
to seek medical attention

When to Seek Emergency Medical Care Emergency Warning Signs

Get medical care right away if the sick person at home :
has difficulty breathing, or chest pain.
has purple or blue discoloration of the lips.
is vomiting and unable to keep liquids down .
has signs of dehydration such as dizziness when standing (hypovolemia), absence of urination, or in infants, a lack of tears when they cry.
has seizures (for example, uncontrolled convulsions) .
is less responsive than normal or becomes confused .
Irritable child who doesn’t want to be held.
Flu-like symptoms improve but then return with fever and worse cough.

Medications to Help Lessen Symptoms of the Flu (fever and aches)

Acetaminophen , Ibuprofen, or other nonsteroidal anti-inflammatory drugs (NSAIDS).
However:
These medications will not lessen how infectious a person is .
Could result in self-intoxication ,check the ingredients on the package
label before taking additional doses.
Need consultation with healthcare provider if receipient has kidney or
stomach problems .

Aspirin
Not to be given to children or teenagers who have the flu ( or any viral infection); as it can cause Reye’s syndrome .
Should be checked for on ingredient labels on over-the-counter cold and flu medications to avoid accidental ingestion .
cool-mist humidifier and a suction bulb
The safest care for flu symptoms in children younger than 2 years of age .
Used to clear away mucus.

Steps to Lessen the Spread of Flu in the Home

Stay informed .
Follow the cough etiquette and teach and model it to your children:
Cover your nose and mouth with a tissue when you cough or
sneeze.
Throw the tissue in the trash after you use it.
Wash your hands often with soap and water, especially after you cough or sneeze. Alcohol-based hand cleaners are also effective.
Avoid touching your eyes, nose or mouth. Germs spread this way.
Try to avoid close contact with sick people.

Stay home for 7 days after your symptoms begin or until you have been symptom-free for 24 hours, whichever is longer.
Keep away from other household members as much as possible. This is to keep you from infecting others and spreading the virus further.
Provide each family member with their own hygienic necessaties eg towels…

Placement of the sick person

Keep the sick person in a room separate from the common areas of the house. For example, a spare bedroom with its own bathroom,to be cleaned daily with household disinfectant .
Keep the sickroom door closed .
Have the sick person wear a surgical mask if they need to be in a common area of the house near other persons.
Stay away from the alien virus invasion!

Protect other persons in the home

The sick person should not have visitors other than caregivers. A phone call is safer than a visit.
If possible, have only one adult in the home take care of the sick person.
Avoid having pregnant women care for the sick person.
Maintain good ventilation in shared household areas (e.g., keeping windows open in restrooms, kitchen, bathroom, etc.).

If you are the caregiver

Avoid being face -to-face with the sick person.
When holding small children who are sick, place their chin on your shoulder so that they will not cough in your face.
I didn’t believe them when they said that smoking was bad for my health… a risk factor for novel H1N1!

Avoid close contact (less than about 6 feet away) with the sick person as much as possible.
Spend the least amount of time possible in close contact and try to wear a facemask (for example, surgical mask) or N95 disposable respirator(it is harder to breathe through an N95 mask for long periods of time)
Get in, get out…

Clean your hands with soap and water or use an alcohol-based hand rub after you touch the sick person or handle used tissues, or laundry.
Talk to your health care provider about taking antiviral medication to prevent the caregiver from getting the flu.
Monitor yourself and household members for flu symptoms and contact a telephone hotline or health care provider if symptoms occur .

Using Facemasks or Respirators

Facemasks and respirators may be purchased at a pharmacy, building supply or hardware store (not off the street).
Used facemasks and N95 respirators should be taken off and placed immediately in the regular trash so they don’t touch anything else.
Avoid re-using disposable facemasks and N95 respirators if possible. If a reusable fabric facemask is used, it should be laundered with normal laundry detergent and tumble-dried in a hot dryer.
After you take off a facemask or N95 respirator, clean your hands with soap and water or an alcohol-based hand sanitizer.

Household Cleaning, Laundry, and Waste Disposal

Throw away tissues and other disposable items used by the sick person in the trash.
Wash your hands after touching used tissues and similar waste.
Keep surfaces (especially bedside tables, surfaces in the bathroom, and toys for children) clean by wiping them down with a household disinfectant according to directions on the product label.
Eating utensils should be washed either in a dishwasher or by hand with water and soap.

Linens, eating utensils, and dishes belonging to those who are sick do not need to be cleaned separately, but importantly these items should not be shared without washing thoroughly first.
Wash linens (such as bed sheets and towels) by using household laundry soap and tumble dry on a hot setting .
Avoid “hugging” laundry prior to washing it to prevent contaminating yourself.
Clean your hands with soap and water or alcohol-based hand rub right after handling dirty laundry.

Pandemic Flu Planning Checklist for Individuals and Families

To plan for a pandemic:
Store a two week supply of water and food.
Periodically check your regular prescription drugs
Have any nonprescription drugs and other health supplies on hand, including pain relievers, stomach remedies, cough and cold medicines, fluids with electrolytes, and vitamins.
Volunteer with local groups to prepare and assist with emergency response.

Ready-to-eat canned meats, fish, fruits, vegetables, beans, and soups
Canned juices
Fluids with electrolytes
Bottled water
Canned or jarred baby food and
formula
Pet food
Protein or fruit bars
Dry cereal or granola
Dried fruit
Peanut butter or nuts
Crackers
Cleansing agent/soap
Soap and water, or
alcohol-based (60-95%)
hand wash
Flashlight
Batteries
Other non-perishable items
Portable radio
Manual can opener
Garbage bags
Tissues, toilet paper, disposable
diapers
Examples of food and non-perishables Examples of medical, health, and emergency supplies:
Thermometer
Prescribed medical supplies such as glucose and blood-pressure monitoring equipment
Vitamins
Medicines for fever , such as acetaminophen or ibuprofen
Anti-diarrheal medication
Be prepared for Power failure, water shortage….

Looks to me like he’s conquered his matador , and has every right to fly……….

http://cursinhopoliusp.blogspot.com	245
http://cursinhopoliusp.blogspot.com.br	66
http://beinghealthyhomeandaway.blogspot.com	21
http://cpoliusp2009.blogspot.com	10
http://upandstreaming.blogspot.com	5
http://www.cursinhopoliusp.blogspot.com.br	3
http://cursinhopoliusp.blogspot.pt	3
http://beinghealthyhomeandaway.blogspot.in	2
http://webcache.googleusercontent.com	1
http://www.cpoliusp2009.blogspot.com	1
http://www.google.com.br	1
http://globaldebateblog.blogspot.com	1
http://beansriceandgold.blogspot.com	1
http://beinghealthyhomeandaway.blogspot.ca	1
http://207.46.192.232	1

2009 H1N1 July 25th update

by Mona Youssef on Jul 25, 2009

Accessibility

Categories

Tags

Upload Details

Usage Rights

15 Embeds 362

Statistics

2009 H1N1 July 25th update — Presentation Transcript